Editorial Expression of Concern: Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures

被引：0

作者：

Jun Iwamoto

Mitsuyoshi Uzawa

机构：

[1] Keio University School of Medicine,Institute for Integrated Sports Medicine

[2] Keiyu Orthopaedic Hospital,Department of Orthopaedic Surgery

来源：

Clinical Rheumatology | 2021年 / 40卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

An Editorial Expression of Concern to this paper has been published: https://doi.org/10.1007/s10067-021-05796-3

引用

页码：3387 / 3387

共 38 条

[1] Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures
Jun Iwamoto
Mitsuyoshi Uzawa
Clinical Rheumatology, 2016, 35 : 205 - 212
[2] Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures (Expression of Concern of Vol 35, Pg 205, 2016)
Iwamoto, Jun
Uzawa, Mitsuyoshi
CLINICAL RHEUMATOLOGY, 2021, 40 (08) : 3387 - 3387
[3] Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures (Expression of Concern of Vol 6, Pg 593, 2010)
不详
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 2137 - 2137
[4] Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures (Publication with Expression of Concern. See vol. 40, pg. 3387, 2021)
Iwamoto, Jun
Uzawa, Mitsuyoshi
CLINICAL RHEUMATOLOGY, 2016, 35 (01) : 205 - 212
[5] RETRACTION: Experience with Alendronate Treatment for Four Years among Japanese Men with Osteoporosis or Osteopenia and Clinical Risk Factors for Fractures (Retraction of Vol 6, Pg 593, 2010)
Iwamoto, J.
Sato, Y.
Uzawa, M.
Takeda, T.
Matsumoto, H.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2022, 18 : 785 - 785
[6] RETRACTED: Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures (Publication with Expression of Concern. See vol. 14, pg. 2137, 2018) (Retracted article. See vol. 18, pg. 785, 2022)
Iwamoto, Jun
Sato, Yoshihiro
Uzawa, Mitsuyoshi
Takeda, Tsuyoshi
Matsumoto, Hideo
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 593 - 600
[7] Risk factors for osteoporosis and osteopenia in men 50 years and older.
Tanaka, T
Latorre, MRO
Jaime, PC
Pippa, MGB
Florindo, AA
Zerbini, CAF
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S510 - S510
[8] Risk Factors for the Development of Osteoporosis and Osteoporotic Fractures Among Older Men
Thomas-John, Maria
Codd, Mary B.
Manne, Sialaja
Watts, Nelson B.
Mongey, Anne-Barbara
JOURNAL OF RHEUMATOLOGY, 2009, 36 (09) : 1947 - 1952
[9] RETRACTED: Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures (Retracted article. See vol. 64, pg. 228, 2023)
Iwamoto, Jun
Sato, Yoshihiro
Uzawa, Mitsuyoshi
Takeda, Tsuyoshi
Matsumoto, Hideo
YONSEI MEDICAL JOURNAL, 2009, 50 (04) : 474 - 481
[10] RETRACTION: Paper "Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures" (vol 50, pg 474, 2009) (Retraction of Vol 50, Pg 474, 2009)
Kim, Changsoo
YONSEI MEDICAL JOURNAL, 2023, 64 (03) : 228 - 228

← 1 2 3 4 →